Chemotherapy

The combination treatment of two or more antihypertensive therapies in patients being treated with ibrutinib can significantly reduce blood pressure, data published in Blood Advances showed.

Chimeric antigen receptor T-cell therapy produced persistent, drug-free remission in patients with one of three different B-cell autoimmune diseases, researchers reported at ASH Annual Meeting and Exhibition.

In this video, Rachna T. Shroff, MD, MS, of University of Arizona Cancer Center, discusses highlights from ASCO Gastrointestinal Cancers Symposium.

A regimen of pembrolizumab plus chemotherapy given before and after surgery induced a pathologic objective response in approximately 60% of patients with advanced gastric cancers, phase 2 study results published in JAMA Oncology showed.

Although an abundance of treatments exist for breast cancer, there are almost no options for screening patients for risk for recurrence or spread of early-stage breast cancer, representing a major unmet need in the field.

Researchers at Sylvester Comprehensive Cancer Center at University of Miami devised an MRI-guided radiation therapy technique using machine learning that may allow for real-time monitoring of glioblastoma treatment response.

Insect venom was the cause of 82.7% of cases of occupational anaphylaxis, followed by food, drugs and latex, according to a study published in Allergy.

Circulating tumor DNA did not successfully predict whether patients with resected stage II colon cancer would benefit from adjuvant chemotherapy, according to findings presented at ASCO Gastrointestinal Cancers Symposium.

A sound wave technique pioneered at University of Michigan has exhibited preliminary efficacy as a treatment for liver cancer.

Oncologists were satisfied with an electronic system for consulting with allergists about hypersensitivity reactions during chemotherapy, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.